Curated By Nelson Vergel | ExcelMale.com | Updated March 2026
Key Takeaways
Retatrutide is a first-in-class triple hormone receptor agonist (GLP-1 + GIP + glucagon) from Eli Lilly, currently in Phase 3 clinical trials under the TRIUMPH program.
In Phase 3 (TRIUMPH-4), participants on the...
Could a single weekly injection deliver unprecedented weight loss while preserving muscle mass and improving cardiovascular health? For men on testosterone replacement therapy (TRT) struggling with stubborn body fat despite optimized hormone levels, this question has taken on profound...